Preprint Article Version 1 Preserved in Portico This version is not peer-reviewed

A Multiplex CRISPR/Cas9 System for Use as an Anti-BmNPV Therapeutic

Zhanqi Dong
ORCID logo ,
Qi Qin
,
Zhigang Hu
,
Peng Chen
,
Liang Huang
,
Jiangqiong Long
,
Ting Tian
,
Cheng Lu
,
Minhui Pan
*
Version 1 : Received: 5 November 2018 / Approved: 7 November 2018 / Online: 7 November 2018 (10:23:52 CET)

How to cite: Dong, Z.; Qin, Q.; Hu, Z.; Chen, P.; Huang, L.; Long, J.; Tian, T.; Lu, C.; Pan, M. A Multiplex CRISPR/Cas9 System for Use as an Anti-BmNPV Therapeutic. Preprints 2018, 2018110159. https://doi.org/10.20944/preprints201811.0159.v1 Dong, Z.; Qin, Q.; Hu, Z.; Chen, P.; Huang, L.; Long, J.; Tian, T.; Lu, C.; Pan, M. A Multiplex CRISPR/Cas9 System for Use as an Anti-BmNPV Therapeutic. Preprints 2018, 2018110159. https://doi.org/10.20944/preprints201811.0159.v1

Abstract

Clustered regularly interspaced short palindromic repeats/associated protein 9 nuclease (CRISPR/Cas9) technology guided by a single-guide RNA (sgRNA) has recently opened a new avenue for antiviral therapy. A unique capability of the CRISPR/Cas9 system is multiple genome engineering. However, there are few applications in insect viruses by a single Cas9 enzyme targeting two or more sgRNA at different genomic sites for simultaneous production of multiple DNA breaks. To address the need for multi-gene editing and sustained delivery of multiplex CRISPR/Cas9-based genome engineering tools, we developed a one-vector (pSL1180-Cas9-U6-sgRNA) system to express multiple sgRNA and Cas9 protein to excise Bombyx mori nucleopolyhedrovirus (BmNPV) in insect cells. Here, ie-1, gp64, lef-11, and dnapol genes were screened and identified as multiple sgRNA editing sites according to the BmNPV system infection and DNA replication mechanism. Furthermore, we constructed a multiplex editing vector sgMultiple to efficiently regulate multiplex gene editing steps and inhibit BmNPV replication after viral infection. This is the first report that describes the application of multiplex CRISPR/Cas9 system inhibiting insect virus replication. This multiplex system can significant enable the potential of CRISPR/Cas9-based multiplex genome engineering in transgenic silkworms.

Keywords

Bombyx mori; BmNPV; antiviral therapeutic; CRISPR/Cas9; multi-gene editing

Subject

Biology and Life Sciences, Insect Science

Copyright: This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Download PDF Download Supplementary

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0
Metrics 0
Get PDF Supplementary Files Cite Share 0
Bookmark BibSonomy Mendeley Reddit Delicious
×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.